Developers of lab and biomanufacturing space, tasked with meeting seemingly unending demand for more product built with refined specifications and top-line tech, are turning to a familiar method for ...

A small biotechnology company was ready to move its vaccine from the laboratory to clinical trials. Even though the company lacked its own manufacturing facilities, it wasn’t ready to put its fate ...